Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection

The authors formulate criteria for an optimal pre-exposure prophylaxis drug candidate, and evaluate existing antiviral drug classes for their suitability.

Detalles Bibliográficos
Autores principales: Derdelinckx, Inge, Wainberg, Mark A, Lange, Joep M. A, Hill, Andrew, Halima, Yasmin, Boucher, Charles A. B
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Policy Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1630715/
https://www.ncbi.nlm.nih.gov/pubmed/17090213
http://dx.doi.org/10.1371/journal.pmed.0030454
_version_ 1782130633169960960
author Derdelinckx, Inge
Wainberg, Mark A
Lange, Joep M. A
Hill, Andrew
Halima, Yasmin
Boucher, Charles A. B
author_facet Derdelinckx, Inge
Wainberg, Mark A
Lange, Joep M. A
Hill, Andrew
Halima, Yasmin
Boucher, Charles A. B
author_sort Derdelinckx, Inge
collection PubMed
description The authors formulate criteria for an optimal pre-exposure prophylaxis drug candidate, and evaluate existing antiviral drug classes for their suitability.
format Text
id pubmed-1630715
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-16307152007-06-30 Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection Derdelinckx, Inge Wainberg, Mark A Lange, Joep M. A Hill, Andrew Halima, Yasmin Boucher, Charles A. B PLoS Med Policy Forum The authors formulate criteria for an optimal pre-exposure prophylaxis drug candidate, and evaluate existing antiviral drug classes for their suitability. Public Library of Science 2006-11 2006-11-07 /pmc/articles/PMC1630715/ /pubmed/17090213 http://dx.doi.org/10.1371/journal.pmed.0030454 Text en © 2006 Derdelinckx et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Policy Forum
Derdelinckx, Inge
Wainberg, Mark A
Lange, Joep M. A
Hill, Andrew
Halima, Yasmin
Boucher, Charles A. B
Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection
title Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection
title_full Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection
title_fullStr Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection
title_full_unstemmed Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection
title_short Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection
title_sort criteria for drugs used in pre-exposure prophylaxis trials against hiv infection
topic Policy Forum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1630715/
https://www.ncbi.nlm.nih.gov/pubmed/17090213
http://dx.doi.org/10.1371/journal.pmed.0030454
work_keys_str_mv AT derdelinckxinge criteriafordrugsusedinpreexposureprophylaxistrialsagainsthivinfection
AT wainbergmarka criteriafordrugsusedinpreexposureprophylaxistrialsagainsthivinfection
AT langejoepma criteriafordrugsusedinpreexposureprophylaxistrialsagainsthivinfection
AT hillandrew criteriafordrugsusedinpreexposureprophylaxistrialsagainsthivinfection
AT halimayasmin criteriafordrugsusedinpreexposureprophylaxistrialsagainsthivinfection
AT bouchercharlesab criteriafordrugsusedinpreexposureprophylaxistrialsagainsthivinfection

Ejemplares similares